XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.20.2

Entity Wide Disclosures | 6 Months Ended
--- | ---
Jun. 30, 2020
Entity Wide Disclosures [Abstract] |
Entity Wide Disclosures | (13) Entity Wide Disclosures Revenue by Category The following table disaggregates our revenue by major source (in thousands):
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Therapeutic Area |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Oncology |  | $ | 65,629 |  |  | $ | 64,661 |  |  | $ | 134,841 |  |  | $ | 120,623 |
Other |  |  | 45,196 |  |  |  | 47,092 |  |  |  | 95,765 |  |  |  | 93,961 |
Metabolic |  |  | 30,210 |  |  |  | 32,367 |  |  |  | 66,285 |  |  |  | 67,368 |
AVAI |  |  | 22,987 |  |  |  | 22,664 |  |  |  | 48,134 |  |  |  | 42,588 |
Cardiology |  |  | 21,755 |  |  |  | 24,409 |  |  |  | 47,654 |  |  |  | 47,059 |
Central Nervous System |  |  | 19,218 |  |  |  | 22,911 |  |  |  | 43,195 |  |  |  | 43,246 |
Total revenue |  | $ | 204,995 |  |  | $ | 214,104 |  |  | $ | 435,874 |  |  | $ | 414,845 |
In the current quarter and for all periods presented, the revenue associated with medical device projects, previously a separate therapeutic area, has been included in the respective therapeutic area that best aligns with the therapeutic focus of the medical device project and represents how management evaluates disaggregated revenue in its internal reporting.

X
- Definition Entity wide disclosure. + References No definition available. + Details
Name: | medp_EntityWideDisclosureTextBlock
Namespace Prefix: | medp_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Entity wide disclosures. + References No definition available. + Details
Name: | medp_EntityWideDisclosuresAbstract
Namespace Prefix: | medp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration